ProfileGDS4718 / 209763_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 64% 70% 98% 63% 84% 18% 24% 72% 84% 72% 75% 71% 18% 22% 35% 75% 80% 32% 30% 25% 79% 80% 72% 80% 74% 31% 84% 24% 71% 18% 17% 72% 67% 34% 56% 54% 22% 82% 60% 97% 74% 13% 71% 42% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.4342264
GSM549102patient 115, normal, homogenized [OPG study]6.8547270
GSM549104patient 119, normal, homogenized [OPG study]11.394298
GSM549108patient 138, normal, homogenized [OPG study]6.3487463
GSM549119patient 077, normal, homogenized [OPG study]8.3008284
GSM549133patient 032, cancer, homogenized [OPG study]4.0251918
GSM549139patient 042, cancer, homogenized [OPG study]4.2711124
GSM549099patient 107, normal, homogenized [OPG study]6.9941872
GSM549109patient 139, normal, homogenized [OPG study]8.2487284
GSM549110patient 046, normal, homogenized [OPG study]7.0432172
GSM549114patient 063, normal, homogenized [OPG study]7.3022975
GSM549122patient 082, normal, homogenized [OPG study]6.9843971
GSM549134patient 033, cancer, homogenized [OPG study]4.0821518
GSM549136patient 036, cancer, homogenized [OPG study]4.1860522
GSM549140patient 044, cancer, homogenized [OPG study]4.7282135
GSM549111patient 047, normal, homogenized [OPG study]7.3838675
GSM549113patient 057, normal, homogenized [OPG study]7.9153480
GSM549132patient 031, cancer, homogenized [OPG study]4.5947632
GSM549137patient 038, cancer, homogenized [OPG study]4.5409330
GSM549142patient 047, cancer, homogenized [OPG study]4.4583525
GSM549100patient 110, normal, homogenized [OPG study]7.6848179
GSM549107patient 135, normal, homogenized [OPG study]7.9089680
GSM549115patient 068, normal, homogenized [OPG study]7.0583372
GSM549116patient 072, normal, homogenized [OPG study]7.9385380
GSM549120patient 078, normal, homogenized [OPG study]7.2573574
GSM549131patient 030, cancer, homogenized [OPG study]4.5315231
GSM549118patient 074, normal, homogenized [OPG study]8.3263284
GSM549129patient 027, cancer, homogenized [OPG study]4.3233224
GSM549123patient 088, normal, homogenized [OPG study]6.9972171
GSM549124patient 006, cancer, homogenized [OPG study]4.1187918
GSM549126patient 015, cancer, homogenized [OPG study]4.0130217
GSM549128patient 025, cancer, homogenized [OPG study]7.1633572
GSM549103patient 117, normal, homogenized [OPG study]6.5794267
GSM549117patient 073, normal, homogenized [OPG study]4.6781734
GSM549138patient 041, cancer, homogenized [OPG study]5.8460256
GSM549141patient 045, cancer, homogenized [OPG study]5.737654
GSM549130patient 028, cancer, homogenized [OPG study]4.2318122
GSM549101patient 111, normal, homogenized [OPG study]8.0016682
GSM549105patient 128, normal, homogenized [OPG study]6.117260
GSM549106patient 134, normal, homogenized [OPG study]11.166997
GSM549112patient 048, normal, homogenized [OPG study]7.256774
GSM549125patient 011, cancer, homogenized [OPG study]3.8791513
GSM549127patient 024, cancer, homogenized [OPG study]7.0716871
GSM549135patient 035, cancer, homogenized [OPG study]5.0403342